Veterinary Medicines

Gafervit raztopina za injiciranje za prašiče

Authorised
  • Cobalt chloride anhydrous
  • Copper chloride
  • Calcium pantothenate
  • Nicotinamide
  • Pyridoxine hydrochloride
  • Riboflavin
  • Thiamine hydrochloride
  • Iron dextran
  • Porcine normal immunoglobulin
Download as PDF

Product identification

Medicine name:
Gafervit raztopina za injiciranje za prašiče
Active substance:
  • Cobalt chloride anhydrous
  • Copper chloride
  • Calcium pantothenate
  • Nicotinamide
  • Pyridoxine hydrochloride
  • Riboflavin
  • Thiamine hydrochloride
  • Iron dextran
  • Porcine normal immunoglobulin
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Cobalt chloride anhydrous
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Copper chloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium pantothenate
    0.02
    milligram(s)
    /
    1.00
    millilitre(s)
  • Nicotinamide
    0.43
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Riboflavin
    0.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thiamine hydrochloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Iron dextran
    7.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Porcine normal immunoglobulin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB03AE10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0147/001
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 18/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."